Recombinant Immunotoxin Targeting Mesothelin Read more about Recombinant Immunotoxin Targeting Mesothelin Australia2012253896Filed on 2012-05-04
Engineered Antibody Constant Domain Molecules Read more about Engineered Antibody Constant Domain Molecules US Patent 9,527,903Filed on 2013-10-01
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Spain07867402.5Filed on 2009-04-24
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) Germany07867402.5Filed on 2009-04-24
Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid Read more about Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid US Application 12/843,238Filed on 2010-07-26
ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER Read more about ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER US Patent 9,266,960Filed on 2013-10-24
Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use Read more about Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US Patent 9,441,048Filed on 2013-05-21
ANTIBODIES FOR TUMOR GANGLIOSIDES Read more about ANTIBODIES FOR TUMOR GANGLIOSIDES Patent Cooperation TreatyPCT/US2011/060759Filed on 2011-11-15
AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY Read more about AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY US Application 14/031,699Filed on 2013-09-19
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer Japan2014-503673Filed on 2013-10-03